Bin Yang,Jeffrey Gilbert Varnes,James Stewart Scott,Thomas Andrew Moss,Daniel Hillebrand ODonovan,Johannes Wilhelmus Maria Nissink,Samantha Jayne Hughes,Bernard Christophe Barlaam
申请号：
US15491345
公开号：
US10125135B2
申请日:
2017.04.19
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The specification relates to compounds of Formula (I):and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
